• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超级增强子衍生的非编码 RNA 在人类癌症中的新兴作用。

The emerging role of super enhancer-derived noncoding RNAs in human cancer.

机构信息

Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.

Department of Endocrinology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

出版信息

Theranostics. 2020 Sep 2;10(24):11049-11062. doi: 10.7150/thno.49168. eCollection 2020.

DOI:10.7150/thno.49168
PMID:33042269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7532672/
Abstract

Super enhancers (SEs) are large clusters of adjacent enhancers that drive the expression of genes which regulate cellular identity; SE regions can be enriched with a high density of transcription factors, co-factors, and enhancer-associated epigenetic modifications. Through enhanced activation of their target genes, SEs play an important role in various diseases and conditions, including cancer. Recent studies have shown that SEs not only activate the transcriptional expression of coding genes to directly regulate biological functions, but also drive the transcriptional expression of non-coding RNAs (ncRNAs) to indirectly regulate biological functions. SE-derived ncRNAs play critical roles in tumorigenesis, including malignant proliferation, metastasis, drug resistance, and inflammatory response. Moreover, the abnormal expression of SE-derived ncRNAs is closely related to the clinical and pathological characterization of tumors. In this review, we summarize the functions and roles of SE-derived ncRNAs in tumorigenesis and discuss their prospective applications in tumor therapy. A deeper understanding of the potential mechanism underlying the action of SE-derived ncRNAs in tumorigenesis may provide new strategies for the early diagnosis of tumors and targeted therapy.

摘要

超级增强子 (SEs) 是一组相邻的增强子的大型簇,它们驱动调节细胞身份的基因的表达; SE 区域可以富集大量转录因子、共因子和增强子相关的表观遗传修饰。通过增强其靶基因的激活,SEs 在包括癌症在内的各种疾病和状况中发挥重要作用。最近的研究表明,SEs 不仅激活编码基因的转录表达以直接调节生物功能,而且还驱动非编码 RNA (ncRNA) 的转录表达以间接调节生物功能。SE 衍生的 ncRNA 在肿瘤发生中发挥关键作用,包括恶性增殖、转移、耐药性和炎症反应。此外,SE 衍生的 ncRNA 的异常表达与肿瘤的临床和病理特征密切相关。在这篇综述中,我们总结了 SE 衍生的 ncRNA 在肿瘤发生中的功能和作用,并讨论了它们在肿瘤治疗中的潜在应用。更深入地了解 SE 衍生的 ncRNA 在肿瘤发生中的作用的潜在机制可能为肿瘤的早期诊断和靶向治疗提供新的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/d61fd97ca3d2/thnov10p11049g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/0a91d8ac02cc/thnov10p11049g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/f1b37e383e1d/thnov10p11049g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/86218139c1f9/thnov10p11049g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/8a1292700695/thnov10p11049g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/d61fd97ca3d2/thnov10p11049g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/0a91d8ac02cc/thnov10p11049g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/f1b37e383e1d/thnov10p11049g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/86218139c1f9/thnov10p11049g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/8a1292700695/thnov10p11049g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e20/7532672/d61fd97ca3d2/thnov10p11049g005.jpg

相似文献

1
The emerging role of super enhancer-derived noncoding RNAs in human cancer.超级增强子衍生的非编码 RNA 在人类癌症中的新兴作用。
Theranostics. 2020 Sep 2;10(24):11049-11062. doi: 10.7150/thno.49168. eCollection 2020.
2
Role of noncoding RNAs in cholangiocarcinoma (Review).非编码 RNA 在胆管癌中的作用(综述)。
Int J Oncol. 2020 Jul;57(1):7-20. doi: 10.3892/ijo.2020.5047. Epub 2020 Apr 15.
3
Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review.非编码 RNA 介导的细胞焦亡在癌症治疗中的作用:综述。
Expert Rev Anticancer Ther. 2024 May;24(5):239-251. doi: 10.1080/14737140.2024.2341737. Epub 2024 Apr 12.
4
Super-enhancers complexes zoom in transcription in cancer.超级增强子复合物在癌症转录中放大。
J Exp Clin Cancer Res. 2023 Jul 28;42(1):183. doi: 10.1186/s13046-023-02763-5.
5
Super-enhancers: A new frontier for glioma treatment.超级增强子:胶质瘤治疗的新前沿。
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188353. doi: 10.1016/j.bbcan.2020.188353. Epub 2020 Feb 26.
6
Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.DNA损伤反应中的非编码RNA:癌症治疗的机遇
Methods Mol Biol. 2018;1699:3-21. doi: 10.1007/978-1-4939-7435-1_1.
7
Noncoding RNAs and pancreatic cancer.非编码RNA与胰腺癌
World J Gastroenterol. 2016 Jan 14;22(2):801-14. doi: 10.3748/wjg.v22.i2.801.
8
Noncoding RNAs in cancer therapy resistance and targeted drug development.非编码 RNA 在癌症治疗耐药性和靶向药物研发中的作用。
J Hematol Oncol. 2019 Jun 7;12(1):55. doi: 10.1186/s13045-019-0748-z.
9
Super enhancer lncRNAs: a novel hallmark in cancer.超级增强子长链非编码 RNA:癌症的一个新标志。
Cell Commun Signal. 2024 Apr 2;22(1):207. doi: 10.1186/s12964-024-01599-6.
10
Extracellular vesicles-mediated noncoding RNAs transfer in cancer.细胞外囊泡介导的非编码RNA在癌症中的转移
J Hematol Oncol. 2017 Feb 23;10(1):57. doi: 10.1186/s13045-017-0426-y.

引用本文的文献

1
Impact of monotherapy and combination therapy with glucagon-like peptide-1 receptor agonists on exosomal and non-exosomal MicroRNA signatures in type 2 diabetes mellitus: a systematic review.胰高血糖素样肽-1受体激动剂单药治疗及联合治疗对2型糖尿病患者外泌体和非外泌体微小RNA特征的影响:一项系统评价
J Transl Med. 2025 Apr 25;23(1):477. doi: 10.1186/s12967-025-06461-y.
2
Identification of a SNAI1 enhancer RNA that drives cancer cell plasticity.鉴定一种驱动癌细胞可塑性的SNAI1增强子RNA。
Nat Commun. 2025 Mar 25;16(1):2890. doi: 10.1038/s41467-025-58032-w.
3
SE-lncRNAs in Cancer: Classification, Subcellular Localisation, Function and Corresponding TFs.

本文引用的文献

1
TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.TP63、SOX2 和 KLF5 建立了一个核心调控回路,该回路控制食管鳞状细胞癌细胞系中的表观遗传和转录模式。
Gastroenterology. 2020 Oct;159(4):1311-1327.e19. doi: 10.1053/j.gastro.2020.06.050. Epub 2020 Jun 30.
2
The function and mechanism of circular RNAs in gastrointestinal tumours.环状 RNA 在胃肠肿瘤中的功能与机制。
Cell Prolif. 2020 Jul;53(7):e12815. doi: 10.1111/cpr.12815. Epub 2020 Jun 8.
3
Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer.
癌症中的SE-lncRNAs:分类、亚细胞定位、功能及相应转录因子
J Cell Mol Med. 2024 Dec;28(24):e70296. doi: 10.1111/jcmm.70296.
4
Role of long noncoding RNAs in diabetes-associated peripheral arterial disease.长链非编码 RNA 在糖尿病相关外周动脉疾病中的作用。
Cardiovasc Diabetol. 2024 Jul 24;23(1):274. doi: 10.1186/s12933-024-02327-7.
5
Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.超级增强子在癌症转移中的作用:机制和治疗靶点。
Mol Cancer. 2024 Jun 7;23(1):122. doi: 10.1186/s12943-024-02033-8.
6
CCAT1 lncRNA is chromatin-retained and post-transcriptionally spliced.CCAT1 lncRNA 是染色质保留和转录后剪接的。
Histochem Cell Biol. 2024 Jul;162(1-2):91-107. doi: 10.1007/s00418-024-02294-w. Epub 2024 May 19.
7
Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review.肾上腺皮质癌中非编码RNA的研究进展与展望:综述
Medicine (Baltimore). 2024 Jan 26;103(4):e36908. doi: 10.1097/MD.0000000000036908.
8
P2RY13 is a prognostic biomarker and associated with immune infiltrates in renal clear cell carcinoma: A comprehensive bioinformatic study.P2RY13是一种预后生物标志物,与肾透明细胞癌中的免疫浸润相关:一项全面的生物信息学研究。
Health Sci Rep. 2023 Dec 1;6(12):e1646. doi: 10.1002/hsr2.1646. eCollection 2023 Dec.
9
Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1.超级增强子调控基因FYB1通过激活IGLL1促进T细胞急性淋巴细胞白血病进展。
J Immunol Res. 2023 Sep 19;2023:3804605. doi: 10.1155/2023/3804605. eCollection 2023.
10
Super-enhancers complexes zoom in transcription in cancer.超级增强子复合物在癌症转录中放大。
J Exp Clin Cancer Res. 2023 Jul 28;42(1):183. doi: 10.1186/s13046-023-02763-5.
靶向YAP1/LINC00152/FSCN1信号轴可预防结直肠癌进展。
Adv Sci (Weinh). 2019 Dec 5;7(3):1901380. doi: 10.1002/advs.201901380. eCollection 2020 Feb.
4
Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.癌症中的增强子 RNA:调控、机制与治疗潜力。
RNA Biol. 2020 Nov;17(11):1550-1559. doi: 10.1080/15476286.2020.1712895. Epub 2020 Jan 19.
5
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
6
DEEPSEN: a convolutional neural network based method for super-enhancer prediction.DEEPSEN:一种基于卷积神经网络的超级增强子预测方法。
BMC Bioinformatics. 2019 Dec 24;20(Suppl 15):598. doi: 10.1186/s12859-019-3180-z.
7
ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.ΔNp63α 是一个超级增强子富集的主调控因子,可控制鼻咽癌的基底到腔面分化转录程序和基因调控网络。
Carcinogenesis. 2020 Sep 24;41(9):1282-1293. doi: 10.1093/carcin/bgz203.
8
Up-regulation of promotes the tumourigenesis in colorectal cancer.的上调促进结直肠癌的肿瘤发生。 (你提供的原文中“Up-regulation of ”后面缺少具体内容)
J Cancer. 2019 Oct 19;10(25):6405-6413. doi: 10.7150/jca.32216. eCollection 2019.
9
SEA version 3.0: a comprehensive extension and update of the Super-Enhancer archive.SEA 版本 3.0:超级增强子档案的全面扩展和更新。
Nucleic Acids Res. 2020 Jan 8;48(D1):D198-D203. doi: 10.1093/nar/gkz1028.
10
Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.lncRNA ADAMTS9-AS2通过上调FUS/MDM2泛素化轴促进胶质母细胞瘤对替莫唑胺耐药的新功能
Front Cell Dev Biol. 2019 Oct 2;7:217. doi: 10.3389/fcell.2019.00217. eCollection 2019.